SinoBiomed To Conduct Clinical Trials In Thailand For China’s First Malaria Vaccine
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - SinoBiomed will conduct Phase IIb clinical trials of its recombinant malaria vaccine in Thailand in cooperation with Bangkok-based Mahidol University, the company announced Aug. 20